GCTK - CIK 0001506983
GlucoTrack, Inc. (GCTK) reported net income of -$19.39M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$19.39M | +14.2% |
| FY 2024 | -$22.60M | -218.4% |
| FY 2023 | -$7.10M | -60.0% |
| FY 2022 | -$4.43M | -9.0% |
| FY 2021 | -$4.07M | -50.9% |
| FY 2020 | -$2.70M | -176.7% |
| FY 2019 | $3.52M | +152.4% |
| FY 2018 | -$6.72M | -165.0% |
| FY 2017 |
GlucoTrack, Inc. (GCTK) reported net income of -$19.39M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, GlucoTrack, Inc.'s net income declined from -$2.36M to -$19.39M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $10.33M |
| +290.9% |
| FY 2016 | -$5.41M | +7.4% |
| FY 2015 | -$5.84M | -296.0% |
| FY 2014 | $2.98M | +130.4% |
| FY 2013 | -$9.80M | -253.4% |
| FY 2012 | -$2.77M | -17.3% |
| FY 2011 | -$2.36M | - |